Furegrelate (sodium) (Standard)

Furegrelate (sodium) (Standard) is the analytical standard of Furegrelate (sodium) . This product is intended for research and analytical applications. Furegrelate Sodium (U-63557A) is a potent, orally available, and selective thromboxane synthase inhibitor. Furegrelate Sodium inhibits human platelet microsomal thromboxane A2 (TxA2) synthase with an IC50 of 15 nM. Furegrelate Sodium is being developed as an antiplatelet agent[1][2].

Product Specifications

CAS Number

[85666-17-7]

Product Name Alternative

U-63557A (Standard)

UNSPSC

12352005

Target

Prostaglandin Receptor; Reference Standards

Related Pathways

GPCR/G Protein; Others

Field of Research

Cardiovascular Disease

Smiles

O=C(C1=CC2=CC(CC3=CC=CN=C3)=CC=C2O1)O[Na]

Molecular Formula

C15H10NNaO3

Molecular Weight

275.23

References & Citations

[1]Gorman RR, et al. Inhibition of platelet thromboxane A2 synthase activity by sodium 5- (3'-pyridinylmethyl) benzofuran-2-carboxylate. Prostaglandins. 1983 Aug;26 (2) :325-42.|[2]Hirenallur-S DK, et al. Furegrelate, a thromboxane synthase inhibitor, blunts the development of pulmonary arterial hypertension in neonatal piglets. Pulm Circ. 2012 Apr-Jun;2 (2) :193-200.